After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38830214.
- Also identified by DOI 10.7326/ANNALS-24-00207-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hong SJ, Lee SJ, Suh Y, et al; T-PASS (Ticagrelor Monotherapy in Patients Treated With New-Generation Drug-Eluting Stents for Acute Coronary Syndrome) Investigators. <b>Stopping aspirin within 1 month after stenting for ticagrelor monotherapy in acute coronary syndrome: the T-PASS randomized noninferiority trial.</b> Circulation. 2024;149:562-573. 37878786.
Medical subject headings
- Acute Coronary Syndrome
- Drug-Eluting Stents
- Dual Anti-Platelet Therapy
- Platelet Aggregation Inhibitors
- Ticagrelor